These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7877984)

  • 21. Biodistribution and toxicity of 2,4-divinyl-nido-o-carboranyldeuteroporphyrin IX in mice.
    Miura M; Micca PL; Heinrichs JC; Gabel D; Fairchild RG; Slatkin DN
    Biochem Pharmacol; 1992 Feb; 43(3):467-76. PubMed ID: 1540204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of Zwitter-Ionic Conjugate of
    Druzina AA; Zhidkova OB; Dudarova NV; Nekrasova NA; Suponitsky KY; Timofeev SV; Bregadze VI
    Molecules; 2021 Nov; 26(21):. PubMed ID: 34771096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT).
    Maruyama K; Ishida O; Kasaoka S; Takizawa T; Utoguchi N; Shinohara A; Chiba M; Kobayashi H; Eriguchi M; Yanagie H
    J Control Release; 2004 Aug; 98(2):195-207. PubMed ID: 15262412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of carborane-containing porphyrins as tumour targeting agents for boron neutron capture therapy.
    Miura M; Micca PL; Fisher CD; Gordon CR; Heinrichs JC; Slatkin DN
    Br J Radiol; 1998 Jul; 71(847):773-81. PubMed ID: 9771389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of pharmacokinetics of 4-borono-2-(18)F-fluoro-L-phenylalanine for boron neutron capture therapy in a glioma-bearing rat model with hyperosmolar blood-brain barrier disruption.
    Hsieh CH; Chen YF; Chen FD; Hwang JJ; Chen JC; Liu RS; Kai JJ; Chang CW; Wang HE
    J Nucl Med; 2005 Nov; 46(11):1858-65. PubMed ID: 16269600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liposomal boron delivery for neutron capture therapy.
    Nakamura H
    Methods Enzymol; 2009; 465():179-208. PubMed ID: 19913168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dodecaborate lipid liposomes as new vehicles for boron delivery system of neutron capture therapy.
    Ueno M; Ban HS; Nakai K; Inomata R; Kaneda Y; Matsumura A; Nakamura H
    Bioorg Med Chem; 2010 May; 18(9):3059-65. PubMed ID: 20371186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro and in vivo evaluation of o-carboranylalanine as a potential boron delivery agent for neutron capture therapy.
    Yong JH; Barth RF; Wyzlic IM; Soloway AH; Rotaru JH
    Anticancer Res; 1995; 15(5B):2033-8. PubMed ID: 8572598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spermidinium closo-dodecaborate-encapsulating liposomes as efficient boron delivery vehicles for neutron capture therapy.
    Tachikawa S; Miyoshi T; Koganei H; El-Zaria ME; Viñas C; Suzuki M; Ono K; Nakamura H
    Chem Commun (Camb); 2014 Oct; 50(82):12325-8. PubMed ID: 25182569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Receptor-targeted liposomal delivery of boron-containing cholesterol mimics for boron neutron capture therapy (BNCT).
    Thirumamagal BT; Zhao XB; Bandyopadhyaya AK; Naranyanasamy S; Johnsamuel J; Tiwari R; Golightly DW; Patel V; Jehning BT; Backer MV; Barth RF; Lee RJ; Backer JM; Tjarks W
    Bioconjug Chem; 2006; 17(5):1141-50. PubMed ID: 16984121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toxicity, biodistribution, and convection-enhanced delivery of the boronated porphyrin BOPP in the 9L intracerebral rat glioma model.
    Ozawa T; Afzal J; Lamborn KR; Bollen AW; Bauer WF; Koo MS; Kahl SB; Deen DF
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):247-52. PubMed ID: 16111595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis, toxicity and biodistribution of two 5,15-di[3,5-(nido-carboranylmethyl)phenyl]porphyrins in EMT-6 tumor bearing mice.
    Vicente MG; Wickramasinghe A; Nurco DJ; Wang HJ; Nawrocky MM; Makar MS; Miura M
    Bioorg Med Chem; 2003 Jul; 11(14):3101-8. PubMed ID: 12818672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemorrhage in mouse tumors induced by dodecaborate cluster lipids intended for boron neutron capture therapy.
    Schaffran T; Jiang N; Bergmann M; Küstermann E; Süss R; Schubert R; Wagner FM; Awad D; Gabel D
    Int J Nanomedicine; 2014; 9():3583-90. PubMed ID: 25114527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood-brain barrier disruption.
    Barth RF; Yang W; Rotaru JH; Moeschberger ML; Joel DD; Nawrocky MM; Goodman JH; Soloway AH
    Cancer Res; 1997 Mar; 57(6):1129-36. PubMed ID: 9067283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of high boron content liposomes and their promising antitumor effect for neutron capture therapy of cancers.
    Koganei H; Ueno M; Tachikawa S; Tasaki L; Ban HS; Suzuki M; Shiraishi K; Kawano K; Yokoyama M; Maitani Y; Ono K; Nakamura H
    Bioconjug Chem; 2013 Jan; 24(1):124-32. PubMed ID: 23214414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Computed tomography imaging of transferrin targeting liposomes encapsulating both boron and iodine contrast agents by convection-enhanced delivery to F98 rat glioma for boron neutron capture therapy.
    Miyata S; Kawabata S; Hiramatsu R; Doi A; Ikeda N; Yamashita T; Kuroiwa T; Kasaoka S; Maruyama K; Miyatake S
    Neurosurgery; 2011 May; 68(5):1380-7; discussion 1387. PubMed ID: 21273928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selectively induced death of macrophages in the synovial lining of murine knee joints using 10B-liposomes and boron neutron capture synovectomy.
    van Lent PL; Krijger GC; Hofkens W; Nievaart VA; Sloetjes AW; Moss RL; Koning GA; van den Berg WB
    Int J Radiat Biol; 2009; 85(10):860-71. PubMed ID: 19639504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The potential of transferrin-pendant-type polyethyleneglycol liposomes encapsulating decahydrodecaborate-(10)B (GB-10) as (10)B-carriers for boron neutron capture therapy.
    Masunaga S; Kasaoka S; Maruyama K; Nigg D; Sakurai Y; Nagata K; Suzuki M; Kinashi Y; Maruhashi A; Ono K
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1515-22. PubMed ID: 17126210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carboranyl peptide-antibody conjugates for neutron-capture therapy: preparation, characterization, and in vivo evaluation.
    Paxton RJ; Beatty BG; Varadarajan A; Hawthorne MF
    Bioconjug Chem; 1992; 3(3):241-7. PubMed ID: 1520728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Towards boron neutron capture therapy: the formulation and preliminary in vitro evaluation of liposomal vehicles for the therapeutic delivery of the dequalinium salt of bis-nido-carborane.
    Theodoropoulos D; Rova A; Smith JR; Barbu E; Calabrese G; Vizirianakis IS; Tsibouklis J; Fatouros DG
    Bioorg Med Chem Lett; 2013 Nov; 23(22):6161-6. PubMed ID: 24080462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.